“…To our knowledge, HAdV-A31 is the only A proposed for vaccination strategy, principally because of its ability to escape the host's immune surveillance. Moreover, limited evolution of clinical isolates of HAdV-A31 indicated low probabilities for the emergence of new subtypes in the recent years [173]. Species B (including types 3,7,11,14,16,21,34,35,50,55) The species B HAdVs (which, as mentioned above are from gorillas) are subdivided into subspecies B1 (types B3, B7, B16, B21 and B50) and B2 (types B11, B14, B34, B35 and B55) based on DNA homology.…”